Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
Trial ID or NCT#
NCT04060641
Status
NOT RECRUITING
Purpose
The purpose of this study is to assess the effectiveness of a multi-gene panel to determine which subjects are likely to respond to renal denervation therapy with Medtronic's Symplicity Spyral™ multi-electrode renal denervation system.
Official Title
Association Between a Multi-Gene Panel and Renal Denervation Effectiveness in Patients With Hypertension
Eligibility Criteria
Ages Eligible for Study: 18 Years to 80 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- 1. Individual is currently or has previously been enrolled in a Medtronic clinical study utilizing the Symplicity Spyral™ multi-electrode renal denervation system. 2. Subject received Renal Denervation. 3. Subject has met the primary efficacy endpoint for the Medtronic Symplicity Spyral study and which arm they were randomized to. 4. Individual agrees to have all study procedures performed, and is competent and willing to provide written, informed consent to participate in this clinical study.
Exclusion Criteria:
- - Unable to provide written, informed, consent
Investigator(s)
David Lee, MD
Cardiologist,
Interventional cardiologist
Professor of Medicine (Cardiovascular Medicine)
View on ClinicalTrials.gov
